Event Type: CLE / CPD, Webinar
Tuesday, July 19, 2016 12:00 p.m. ET
Drug and device manufacturers often struggle to correctly determine their products’ “country of origin” thanks to ever-changing global supply chains and the fact that different government agencies employ entirely different legal standards. As a result, a product’s country of origin may vary based on which agency is requiring a determination. This has caused considerable confusion and, yet, compliance has never been more important as multi-million dollar False Claims Act actions become more frequent for companies that incorrectly certify the origin of their products to the government.
This webinar examines the numerous regulatory requirements that companies must take into consideration to ensure compliance over time. It also explains the risks of non-compliance in the context of both administrative penalties and False Claims Act actions initiated by the government and whistleblowers.
To view this webinar on demand, please click here.